Literature DB >> 28176327

Women treated for epilepsy during pregnancy: outcomes from a nationwide population-based cohort study.

Miia Artama1, Jemina Braumann1, Jani Raitanen1,2, Jukka Uotila3, Mika Gissler4, Jouko Isojärvi5, Anssi Auvinen1,6.   

Abstract

INTRODUCTION: Women with epilepsy (WWE) are generally treated as a risk group during pregnancy, but over 90% of pregnant WWE have favorable pregnancies. However, the risk of some pregnancy and delivery complications may be increased among WWE, especially those on antiepileptic drugs.
MATERIAL AND METHODS: This nationwide, retrospective population-based cohort study includes WWE who gave birth in Finland during 1987-2008 (n = 1737) and the reference cohort of a random sample of women without epilepsy (n = 4357). Identification of the cohorts, and information on hospitalizations and deliveries were obtained from the Finnish Health Registers and population statistics. Multivariate analyses were conducted by binomial regression.
RESULTS: WWE were more often hospitalized during pregnancy for accidents or other external causes [adjusted risk ratio (aRR) 1.74, 95% confidence interval (CI) 0.98-3.09], premature rupture of membranes (aRR 1.75, 95% CI 1.14-2.69) and premature contractions (aRR 1.75, 95% CI 1.36-2.23). Hospitalizations for infections were more frequent in WWE (1.4% vs. 0.4%, aRR 3.15, 95% CI 1.72-5.76). The risk for induction of delivery or a cesarean section was increased in WWE. There was no difference in premature deliveries between the groups, but the risk of being small for gestational age (aRR 1.57, 95% CI 1.23-2.01), admission to neonatal intensive care unit (aRR 1.66, 95% CI 1.39-1.97), and need for respiratory care (aRR 2.37, 95% CI 1.57-3.60) was clearly increased in the offspring of WWE.
CONCLUSIONS: WWE are at an increased risk of complications and hospitalizations during pregnancy and delivery. However, the majority of WWE have a normal pregnancy and delivery.
© 2017 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Epilepsy; cesarean section; delivery; high-risk pregnancy; pregnancy

Mesh:

Substances:

Year:  2017        PMID: 28176327     DOI: 10.1111/aogs.13109

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  4 in total

1.  Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy.

Authors:  Hyunmi Kim; Edward Faught; David J Thurman; Jesse Fishman; Linda Kalilani
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

2.  Short- and long-term complications of in utero exposure to lamotrigine.

Authors:  Merav Cohen-Israel; Itai Berger; Einat Y Martonovich; Gil Klinger; Bracha Stahl; Nehama Linder
Journal:  Br J Clin Pharmacol       Date:  2017-10-22       Impact factor: 4.335

3.  The impact of maternal epilepsy on delivery and neonatal outcomes.

Authors:  Shahla Melikova; Hijran Bagirova; Sharif Magalov
Journal:  Childs Nerv Syst       Date:  2019-11-30       Impact factor: 1.475

4.  Pregestational neurological disorders among women of childbearing age-Nationwide data from a 13-year period in Hungary.

Authors:  Dániel Bereczki; Mónika Bálint; András Ajtay; Ferenc Oberfrank; Ildikó Vastagh
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.